TXMD financials
TherapeuticsMD (TXMD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- TXMD revenue was $3.02M in fiscal 2025, net income -$569.00K.
TXMD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.02M | – | -$4.39M | -$569.00K | -0.05 |
| 2024 | $1.76M | – | -$6.11M | -$2.18M | -0.19 |
| 2023 | $1.30M | $1.30M | -$8.52M | -$10.28M | -0.99 |
| 2022 | $69.96M | $68.57M | $1.19M | $112.00M | 0.24 |
| 2021 | $2.57M | $1.17M | -$79.58M | -$172.41M | -0.43 |
| 2020 | $64.87M | $48.90M | -$155.54M | -$183.52M | -0.67 |